We determined the molecular mechanisms underlying PD using the Aco2 knock-in (KI) mouse and Drosophila models using the activity-reducing variant, as well as cell models with Aco2 RNAi-based knockdown or specific blockade by tricarballylic acid (TA). This evidence concerns the gene ACO2 and Parkinson disease.